DOCSLIB.ORG

Structural Basis for the Specific Inhibition of Heterotrimeric Gq

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Structural Basis for the Specific Inhibition of Heterotrimeric Gq Structural basis for the specific inhibition of heterotrimeric protein by a small molecule Gq Akiyuki Nishimuraa,1, Ken Kitanob,1, Jun Takasakic, Masatoshi Taniguchic, Norikazu Mizunoa, Kenji Tagoa, Toshio Hakoshimab,2, and Hiroshi Itoha,2 aSignal Transduction Laboratory and bStructural Biology Laboratory, Nara Institute of Science and Technology, 8916-5 Takayama, Ikoma, Nara 630-0192, Japan; and cAstellas Pharma Inc., 21 Miyukigaoka, Tsukuba, Ibaraki 305-8585, Japan Edited* by Alfred G. Gilman, University of Texas Southwestern Medical Center, Dallas, TX, and approved June 15, 2010 (received for review March 18, 2010) Heterotrimeric GTP-binding proteins (G proteins) transmit extracel- tracellular calcium ion mobilization and serum response element lular stimuli perceived by G protein-coupled receptors (GPCRs) to (SRE)-mediated transcription stimulated by several receptors intracellular signaling cascades. Hundreds of GPCRs exist in humans coupled to Gq, but not those coupled to Gi,Gs,orG15 (5). and are the targets of a large percentage of the pharmaceutical YM-254890 also exhibited antithrombotic and thrombolytic drugs used today. Because G proteins are regulated by GPCRs, small effects in an electrically induced carotid artery thrombosis model molecules that directly modulate G proteins have the potential to in rats (6). YM-254890 is the first and only compound that become therapeutic agents. However, strategies to develop mod- specifically inhibits Gq signaling. Accordingly, it is an invaluable ulators have been hampered by a lack of structural knowledge of tool for analyzing G protein activation and Gq-mediated cell targeting sites for specific modulator binding. Here we present the responses. However, the details of the inhibitory mechanism of mechanism of action of the cyclic depsipeptide YM-254890, which YM-254890 remain to be revealed. is a recently discovered Gq-selective inhibitor. YM-254890 specifi- In this study, we carried out the biochemical characterization α cally inhibits the GDP/GTP exchange reaction of subunit of Gq of YM-254890 using purified G proteins in vitro and determined α α protein (G q) by inhibiting the GDP release from G q. X-ray crystal the X-ray crystal structure of the heterotrimeric Gq protein com- structure analysis of the Gαqβγ–YM-254890 complex shows that plexed with YM-254890. Our results revealed a unique inhibitory YM-254890 binds the hydrophobic cleft between two interdomain mechanism by which YM-254890 selectively blocks GDP release α linkers connecting the GTPase and helical domains of the G q. The from the Gq protein. binding stabilizes an inactive GDP-bound form through direct interactions with switch I and impairs the linker flexibility. Our stu- Results dies provide a novel targeting site for the development of small Specific Inhibition of Gq Family Members by YM-254890. Previously, it molecules that selectively inhibit each Gα subunit and an insight was reported that YM-254890 blocks agonist-induced GTPγS into the molecular mechanism of G protein activation. binding to Gq∕11 in crude cell membranes (5). This finding sug- gests the possibility that YM-254890 directly binds to Gαq and G protein ∣ crystal structure ∣ specific inhibitor inhibits the GDP/GTP exchange. To test this, we first performed 35 an in vitro ½ SGTPγS binding assay using purified Gαq protein. γ α eterotrimeric guanine nucleotide-binding proteins (G pro- YM-254890 blocked spontaneous GTP S binding to G q in a con- teins) serve as critical relays that transmit extracellular centration-dependent manner, suggesting a stoichiometric inter- H α A B stimuli perceived by G protein-coupled receptors (GPCRs) at action between G q and YM-254890 (Fig. 1 and ). On the the cell surface to intracellular signaling cascades (1–3). Hetero- other hand, YM-254890 had no effect on the spontaneous GTPγS α α α α trimeric G proteins comprise three subunits, α, β, and γ. The Gα binding to G s,G i1,G o, and G 13 (Fig. S1). GTP binding to subunit conserves the Ras-like GTPase domain that is essential GDP-bound Gα consists of two reactions: dissociation of bound for hydrolyzing GTP to GDP. In an in vivo resting state, the GDP and binding of GTP to nucleotide-free Gα. The dissociation Gα subunit usually exists in the GDP-bound state and forms a of GDP is a rate-limiting step in the GDP/GTP exchange reac- trimer with the β and γ subunits. A ligand-activated GPCR acts tion. We investigated the effect of YM-254890 on GDP dissocia- 3 3 as a guanine nucleotide exchange factor (GEF) that stimulates tion from Gαq. ½ HGDP was preloaded on Gαq, and ½ HGDP exchange of bound GDP for GTP on the Gα subunit. GTP bind- released from Gαq was analyzed in the presence or absence of ing alters three flexible regions, switches I, II, and III, of Gα, lead- YM-254890. YM-254890 blocked GDP dissociation from Gαq ing to Gβγ dissociation and the subsequent binding of Gα and in a concentration-dependent manner (Fig. 1 C and D), indicating Gβγ to downstream effectors. Signal termination is achieved that YM-254890 acts as a Gαq-specific guanine nucleotide disso- by GTP hydrolysis, resulting in the reformation of an inactive ciation inhibitor (GDI). − heterotrimer. Aluminum fluoride (AlF4 ) is known to activate Gα proteins GPCR-mediated signal transduction controls a wide variety of by mimicking the γ-phosphate of GTP in the presence of GDP − organ functions through multiple signaling pathways (3). The 15 (7, 8). Thus, the addition of AlF4 induces conformational human genes encoding Gα subunits are categorized into four sub- families: Gαs,GαI,Gαq, and Gα12. The multiplicity of receptor-G Author contributions: A.N., K.K., T.H., and H.I. designed research; A.N., K.K., N.M., and K.T. protein interactions makes it difficult to analyze the intracellular performed research; J.T. and M.T. contributed new reagents/analytic tools; A.N., K.K., T.H., signaling network. The most straightforward approach is to apply and H.I. analyzed data; and A.N., K.K., T.H., and H.I. wrote the paper. a specific inhibitor or activator for one type of G protein. How- The authors declare no conflict of interest. ever, until now, availability of small molecules has been limited *This Direct Submission article had a prearranged editor. α to a subset of G subunits. Strategies to develop small molecule Data deposition: The atomic coordinates and structure factors have been deposited in the inhibitors have been hampered by a lack of structural information Protein Data Bank, www.pdb.org (PDB ID code 3AH8). about the inhibitor binding site on the molecular surface. 1A.N. and K.K. contributed equally to this work. To identify such an inhibitor binding site, we focused our 2To whom correspondence may be addressed. E-mail: [email protected] or hakosima@ studies on the cyclic depsipeptide YM-254890, which was isolated bs.naist.jp. Chromobacterium from sp. QS3666 as an inhibitor of ADP- This article contains supporting information online at www.pnas.org/lookup/suppl/ induced platelet aggregation (4). YM-254890 strongly inhibits in- doi:10.1073/pnas.1003553107/-/DCSupplemental. 13666–13671 ∣ PNAS ∣ August 3, 2010 ∣ vol. 107 ∣ no. 31 www.pnas.org/cgi/doi/10.1073/pnas.1003553107 Downloaded by guest on September 27, 2021 teins in lysates from mammalian cells, because both Gα14 and Gα16 proteins were difficult to purify. The results of a previous study (5) and those of our studies indicate that YM-254890 se- lectively inhibits Gαq,Gα11, and Gα14 among mammalian Gα members. To examine whether YM-254890 inhibits Gαq bound to Gβγ, we prepared heterotrimer His-Gαi/qβ1γ2C68S (henceforth, re- ferred to as His-Gαi/qβγ), which contains His-Gαi/q,Gβ1, and non- prenylated His-Gγ2C68S. Gαi/q is a soluble and functional Gαq chimera in which the wild-type N-terminal helix was replaced with that of Gαi1 (11). We compared the YM-254890 sensitivity of monomeric His-Gαi/q and heterotrimeric His-Gαi/qβγ by using the ½35SGTPγS binding assay. YM-254890 inhibited the GTPγS binding to His-Gαi/qβγ as well as Gβγ-free His-Gαi/q (Fig. S3). Overall Structure of Heterotrimeric G Protein Complexed with YM- 254890. To clarify the molecular basis of the YM-254890 action, the crystal structure of Gαi/qβγ bound to YM-254890 was deter- mined at a 2.9 Å resolution (Table S1). The structure reveals the heterotrimer in which Gγ2-bound Gβ1 forms extensive contacts γ Fig. 1. Inhibitory effects of YM-254890. (A) Inhibition of GTP S binding of with Gαi/q, which consists of the N-terminal helix as well as the α α G q. Purified G q (100 nM) preincubated without (filled circles) or with (open GTPase and helical domains (Fig. 2A). The major α/β interface μ ð Þ circles) 10 M YM-254890 was assayed in the presence of 300 mM NH4 2SO4. covers the N-terminal helix and switch II from the GTPase do- (B) Dose-dependent inhibition of GTPγS binding to Gαq. YM-254890-preincu- main, but not the helical domain, of Gαi/q. GDP binds to a cleft bated Gαq was incubated with GTPγS for 120 min. (C) Inhibition of GDP dis- 3 between the GTPase and helical domains without contacting Gβγ. sociation from Gαq. ½ HGDP dissociation from Gαq (50 nM) was monitored without (filled circles) or with (open circles) 10 μM YM-254890 in the presence These structural characteristics are basically similar to the other of 500 μM unlabeled GDP. (D) Dose-dependent inhibition of GDP dissociation reported G protein heterotrimer structures (12, 13). YM-254890 α Æ : : from G q (120 min). Each value represents the mean S D from three inde- docks into the cleft between Linker 1 and Switch I (Linker 2), pendent experiments.
Load more

Recommended publications
  • Predicting Coupling Probabilities of G-Protein Coupled Receptors Gurdeep Singh1,2,†, Asuka Inoue3,*,†, J
    Published online 30 May 2019 Nucleic Acids Research, 2019, Vol. 47, Web Server issue W395–W401 doi: 10.1093/nar/gkz392 PRECOG: PREdicting COupling probabilities of G-protein coupled receptors Gurdeep Singh1,2,†, Asuka Inoue3,*,†, J. Silvio Gutkind4, Robert B. Russell1,2,* and Francesco Raimondi1,2,* 1CellNetworks, Bioquant, Heidelberg University, Im Neuenheimer Feld 267, 69120 Heidelberg, Germany, 2Biochemie Zentrum Heidelberg (BZH), Heidelberg University, Im Neuenheimer Feld 328, 69120 Heidelberg, Germany, 3Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Miyagi 980-8578, Japan and 4Department of Pharmacology and Moores Cancer Center, University of California, San Diego, La Jolla, CA 92093, USA Received February 10, 2019; Revised April 13, 2019; Editorial Decision April 24, 2019; Accepted May 01, 2019 ABSTRACT great use in tinkering with signalling pathways in living sys- tems (5). G-protein coupled receptors (GPCRs) control multi- Ligand binding to GPCRs induces conformational ple physiological states by transducing a multitude changes that lead to binding and activation of G-proteins of extracellular stimuli into the cell via coupling to situated on the inner cell membrane. Most of mammalian intra-cellular heterotrimeric G-proteins. Deciphering GPCRs couple with more than one G-protein giving each which G-proteins couple to each of the hundreds receptor a distinct coupling profile (6) and thus specific of GPCRs present in a typical eukaryotic organism downstream cellular responses. Determining these coupling is therefore critical to understand signalling. Here, profiles is critical to understand GPCR biology and phar- we present PRECOG (precog.russelllab.org): a web- macology. Despite decades of research and hundreds of ob- server for predicting GPCR coupling, which allows served interactions, coupling information is still missing for users to: (i) predict coupling probabilities for GPCRs many receptors and sequence determinants of coupling- specificity are still largely unknown.
    [Show full text]
  • G-Protein ␤␥-Complex Is Crucial for Efficient Signal Amplification in Vision
    The Journal of Neuroscience, June 1, 2011 • 31(22):8067–8077 • 8067 Cellular/Molecular G-Protein ␤␥-Complex Is Crucial for Efficient Signal Amplification in Vision Alexander V. Kolesnikov,1 Loryn Rikimaru,2 Anne K. Hennig,1 Peter D. Lukasiewicz,1 Steven J. Fliesler,4,5,6,7 Victor I. Govardovskii,8 Vladimir J. Kefalov,1 and Oleg G. Kisselev2,3 1Department of Ophthalmology and Visual Sciences, Washington University School of Medicine, St. Louis, Missouri 63110, Departments of 2Ophthalmology and 3Biochemistry and Molecular Biology, Saint Louis University School of Medicine, Saint Louis, Missouri 63104, 4Research Service, Veterans Administration Western New York Healthcare System, and Departments of 5Ophthalmology (Ross Eye Institute) and 6Biochemistry, University at Buffalo/The State University of New York (SUNY), and 7SUNY Eye Institute, Buffalo, New York 14215, and 8Sechenov Institute for Evolutionary Physiology and Biochemistry, Russian Academy of Sciences, Saint Petersburg 194223, Russia A fundamental question of cell signaling biology is how faint external signals produce robust physiological responses. One universal mechanism relies on signal amplification via intracellular cascades mediated by heterotrimeric G-proteins. This high amplification system allows retinal rod photoreceptors to detect single photons of light. Although much is now known about the role of the ␣-subunit of the rod-specific G-protein transducin in phototransduction, the physiological function of the auxiliary ␤␥-complex in this process remains a mystery. Here, we show that elimination of the transducin ␥-subunit drastically reduces signal amplification in intact mouse rods. The consequence is a striking decline in rod visual sensitivity and severe impairment of nocturnal vision. Our findings demonstrate that transducin ␤␥-complex controls signal amplification of the rod phototransduction cascade and is critical for the ability of rod photoreceptors to function in low light conditions.
    [Show full text]
  • Transducin ␤-Subunit Can Interact with Multiple G-Protein ␥-Subunits to Enable Light Detection by Rod Photoreceptors
    New Research Sensory and Motor Systems Transducin ␤-Subunit Can Interact with Multiple G-Protein ␥-Subunits to Enable Light Detection by Rod Photoreceptors Paige M. Dexter,1 Ekaterina S. Lobanova,2 Stella Finkelstein,2 William J. Spencer,1 Nikolai P. Skiba,2 and Vadim Y. Arshavsky1,2 DOI:http://dx.doi.org/10.1523/ENEURO.0144-18.2018 1Department of Pharmacology and Cancer Biology, Duke University School of Medicine, Durham, North Carolina 27710 and 2Albert Eye Research Institute, Duke University, Durham, North Carolina 27710 Visual Overview The heterotrimeric G-protein transducin mediates visual signaling in vertebrate photoreceptor cells. Many aspects of the function of transducin were learned from knock-out mice lacking its individual subunits. Of particular interest is ␥ ␥ the knockout of its rod-specific -subunit (G 1). Two stud- ies using independently generated mice documented that this knockout results in a considerable Ͼ60-fold reduction in the light sensitivity of affected rods, but provided dif- ␣ ␣ ferent interpretations of how the remaining -subunit (G t) ␤ ␥ mediates phototransduction without its cognate G 1 1- subunit partner. One study found that the light sensitivity ␣ reduction matched a corresponding reduction in G t con- tent in the light-sensing rod outer segments and proposed ␣ ␤ that G t activation is supported by remaining G 1 asso- ciating with other G␥ subunits naturally expressed in pho- toreceptors. In contrast, the second study reported the same light sensitivity loss but a much lower, only approx- ␣ imately sixfold, reduction of G t and proposed that the light responses of these rods do not require G␤␥ at all. To resolve this controversy and elucidate the mechanism ␥ driving visual signaling in G 1 knock-out rods, we analyzed both mouse lines side by side.
    [Show full text]
  • Multi-Functionality of Proteins Involved in GPCR and G Protein Signaling: Making Sense of Structure–Function Continuum with In
    Cellular and Molecular Life Sciences (2019) 76:4461–4492 https://doi.org/10.1007/s00018-019-03276-1 Cellular andMolecular Life Sciences REVIEW Multi‑functionality of proteins involved in GPCR and G protein signaling: making sense of structure–function continuum with intrinsic disorder‑based proteoforms Alexander V. Fonin1 · April L. Darling2 · Irina M. Kuznetsova1 · Konstantin K. Turoverov1,3 · Vladimir N. Uversky2,4 Received: 5 August 2019 / Revised: 5 August 2019 / Accepted: 12 August 2019 / Published online: 19 August 2019 © Springer Nature Switzerland AG 2019 Abstract GPCR–G protein signaling system recognizes a multitude of extracellular ligands and triggers a variety of intracellular signal- ing cascades in response. In humans, this system includes more than 800 various GPCRs and a large set of heterotrimeric G proteins. Complexity of this system goes far beyond a multitude of pair-wise ligand–GPCR and GPCR–G protein interactions. In fact, one GPCR can recognize more than one extracellular signal and interact with more than one G protein. Furthermore, one ligand can activate more than one GPCR, and multiple GPCRs can couple to the same G protein. This defnes an intricate multifunctionality of this important signaling system. Here, we show that the multifunctionality of GPCR–G protein system represents an illustrative example of the protein structure–function continuum, where structures of the involved proteins represent a complex mosaic of diferently folded regions (foldons, non-foldons, unfoldons, semi-foldons, and inducible foldons). The functionality of resulting highly dynamic conformational ensembles is fne-tuned by various post-translational modifcations and alternative splicing, and such ensembles can undergo dramatic changes at interaction with their specifc partners.
    [Show full text]
  • How Activated Receptors Couple to G Proteins
    Commentary How activated receptors couple to G proteins Heidi E. Hamm* Department of Pharmacology, Vanderbilt University Medical Center, Nashville, TN 37232-6600 protein-coupled receptors (GPCRs) vide several new approaches to these ques- Gare involved in the control of every tions and important new information aspect of our behavior and physiology. about the active conformation of rhodop- This is the largest class of receptors, with sin and how it contacts the G protein several hundred GPCRs identified thus (13–15, 35). far. Examples are receptors for hormones Rhodopsin signal transduction in rods such as calcitonin and luteinizing hor- and cones underlies our ability to see both mone or neurotransmitters such as sero- in dim light (rod vision) and in color (cone tonin and dopamine. G protein-coupled vision). Different rhodopsins absorb light receptors can be involved in pathological maximally at different light wavelengths, processes as well and are linked to numer- and on activation they activate rod or cone ous diseases, including cardiovascular and transducins. Transducins activate rod and mental disorders, retinal degeneration, cone cGMP phosphodiesterases, causing cancer, and AIDS. More than half of all rapid light-activated cGMP breakdown, drugs target GPCRs and either activate or resultant closure of cGMP-sensitive chan- inactivate them. Binding of specific li- nels, and photoreceptor cell hyperpolar- gands, such as hormones, neurotransmit- ization and inhibition of photoreceptor ters, chemokines, lipids, and glycopro- neurotransmitter release. The study of teins, activates GPCRs by inducing or visual signal transduction has provided stabilizing a new conformation in the recep- many firsts. The major breakthroughs in tor (1, 2).
    [Show full text]
  • Gi- and Gs-Coupled Gpcrs Show Different Modes of G-Protein Binding
    Gi- and Gs-coupled GPCRs show different modes of G-protein binding Ned Van Epsa, Christian Altenbachb,c, Lydia N. Caroa,1, Naomi R. Latorracad,e,f,g, Scott A. Hollingsworthd,e,f,g, Ron O. Drord,e,f,g, Oliver P. Ernsta,h,2, and Wayne L. Hubbellb,c,2 aDepartment of Biochemistry, University of Toronto, Toronto, ON M5S 1A8, Canada; bStein Eye Institute, University of California, Los Angeles, CA 90095; cDepartment of Chemistry and Biochemistry, University of California, Los Angeles, CA 90095; dDepartment of Computer Science, Stanford University, Stanford, CA 94305; eDepartment of Structural Biology, Stanford University, Stanford, CA 94305; fDepartment of Molecular and Cellular Physiology, Stanford University, Stanford, CA 94305; gInstitute for Computational and Mathematical Engineering, Stanford University, Stanford, CA 94305; and hDepartment of Molecular Genetics, University of Toronto, Toronto, ON M5S 1A8, Canada Contributed by Wayne L. Hubbell, January 17, 2018 (sent for review December 20, 2017; reviewed by David S. Cafiso and Thomas P. Sakmar) More than two decades ago, the activation mechanism for the differing only by specific side-chain interactions, or is there a membrane-bound photoreceptor and prototypical G protein-coupled specificity code in the receptor involving the allowed magnitude of receptor (GPCR) rhodopsin was uncovered. Upon light-induced changes displacement of particular helices? Of considerable interest are in ligand–receptor interaction, movement of specific transmembrane GPCRs which couple to multiple G-protein subtypes and can helices within the receptor opens a crevice at the cytoplasmic surface, sample diverse conformational landscapes. allowing for coupling of heterotrimeric guanine nucleotide-binding In the present study, SDSL and double electron–electron reso- proteins (G proteins).
    [Show full text]
  • Small G-Protein They Bind GTP, and “OFF” After the GTP Has Been Hydrolyzed to GDP (Which in Turn Remains Bound)
    MONOMERIC G-PROTEINS (GTPases) In addition to heterotrimeric G-proteins, there is a superfamily of small monomeric G-proteins. Their size is around 21 kDa, approximately one half of the average size of the subunits of heterotrimeric proteins. These small proteins also operate as switches, which are “ON” when Small G-protein they bind GTP, and “OFF” after the GTP has been hydrolyzed to GDP (which in turn remains bound). There is a larger family of small GTP-binding switch proteins, related to G Monomeric G-proteins are activated by proteins which induce a conformational change resulting in reduced affinity to GDP, and thus in G-protein : heterotrimeric G proteins GDP release. The general term for such proteins is GEF (guanine nucleotide exchange factor). The GEFs of the small G-proteins are not the activated receptors, but rather proteins downstream the signaling cascade. GEFs vary with regard to their mode of activation and their selectivity for specific monomeric G-proteins. Small GTP-binding proteins include (roles indicated): initiation & elongation factors (protein synthesis). Compared to the subunit of heterotrimeric G-proteins, GTPase activity Ras (growth factor signal cascades). of the monomeric G-proteins is very low in the absence of interference. Rab (vesicle targeting and fusion). However, association with a protein of the GAP (GTPase-activating ARF (forming vesicle coatomer coats). protein) type results in very rapid GTP hydrolysis. Ran (transport of proteins into & out of the nucleus). As in the case of GEFs, the activation state of GAPs can be regulated, and Rho (regulation of actin cytoskeleton) GAPs are selective with regard to the small G-proteins they affect.
    [Show full text]
  • The Functional Significance of G Protein -Coupled Receptor Dimerization
    THE FUNCTIONAL SIGNIFICANCE OF G PROTEIN-COUPLED RECEPTOR DIMERIZATION by Matthew R. Whorton A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy (Pharmacology) in The University of Michigan 2008 Doctoral Committee: Assistant Professor Roger K. Sunahara, Chair Assistant Professor Jorge A. Iñiguez-Lluhí Professor Jennifer J. Linderman Professor Richard R. Neubig Professor William B. Pratt Associate Professor John J. G. Tesmer To my parents and Jen for their love, support, and encouragement. ii ACKNOWLEDGEMENTS I would like to thank my advisor Roger Sunahara for his guidance and support. I would also like to extend my gratitude to other members of the Sunahara lab, both past and present, as well as members of the Neubig and Tesmer labs for thoughtful discussions and comments during lab meetings. I would also like to extend a great deal of gratitude to several collaborators who have provided their expertise to various aspects of my research. At Stanford University, Mike Bokoch and Soren Rasmussen in Brian Kobilka’s lab and Bo Huang in Richard Zare’s lab were instrumental in fluorescently labeling β2AR and then imaging it with their powerful TIRF single molecule setup. Beata Jastrzebska and Paul Park in Krzysztof Palczewski’s lab at Case Western University were also invaluable in providing purified rhodopsin as well as performing transducin activation assays. And finally, I would like to thank Dimitrios Fotiadis in Andrea Engel’s lab for using their various microscopy techniques to image rhodopsin-HDL complexes. I would also like to thank my friends and roommates through out the years who have helped to enrich the graduate school experience.
    [Show full text]
  • Roles for Regulator of G Protein Signaling Proteins in Synaptic Signaling and Plasticity
    1521-0111/89/2/273–286$25.00 http://dx.doi.org/10.1124/mol.115.102210 MOLECULAR PHARMACOLOGY Mol Pharmacol 89:273–286, February 2016 Copyright ª 2016 by The American Society for Pharmacology and Experimental Therapeutics MINIREVIEW Roles for Regulator of G Protein Signaling Proteins in Synaptic Signaling and Plasticity Kyle J. Gerber, Katherine E. Squires, and John R. Hepler Programs in Molecular and Systems Pharmacology (K.J.G., K.E.S., J.R.H.) and Neuroscience (J.R.H.), Department of Downloaded from Pharmacology (K.J.G., K.E.S., J.R.H.), Emory University School of Medicine, Atlanta, Georgia Received October 26, 2015; accepted December 10, 2015 ABSTRACT The regulator of G protein signaling (RGS) family of proteins synaptic transmission, and synaptic plasticity, which are neces- molpharm.aspetjournals.org serves critical roles in G protein-coupled receptor (GPCR) and sary for central nervous system physiology and behavior. heterotrimeric G protein signal transduction. RGS proteins are Accumulating evidence has revealed key roles for specific RGS best understood as negative regulators of GPCR/G protein proteins in multiple signaling pathways at neuronal synapses, signaling. They achieve this by acting as GTPase activating regulating both pre- and postsynaptic signaling events and proteins (GAPs) for Ga subunits and accelerating the turnoff of G synaptic plasticity. Here, we review and highlight the current protein signaling. Many RGS proteins also bind additional knowledge of specific RGS proteins (RGS2, RGS4, RGS7, signaling partners that either regulate their functions or enable RGS9-2, and RGS14) that have been clearly demonstrated to them to regulate other important signaling events.
    [Show full text]
  • Comprehensive Analysis of Heterotrimeric G-Protein Complex Di- Ing, Induced by Binding of the Agonist Neurotensin (NT) (Fig
    Comprehensive analysis of heterotrimeric G-protein PNAS PLUS complex diversity and their interactions with GPCRs in solution Matthias Hillenbrand, Christian Schori, Jendrik Schöppe, and Andreas Plückthun1 Department of Biochemistry, University of Zurich, 8057 Zurich, Switzerland Edited by Hartmut Michel, Max Planck Institute of Biophysics, Frankfurt, Germany, and approved January 26, 2015 (received for review September 13, 2014) Agonist binding to G-protein–coupled receptors (GPCRs) triggers and, more recently, for GPCRs (13–15), the only structural snap- signal transduction cascades involving heterotrimeric G proteins as shot of the interaction between a GPCR and a G protein is pro- key players. A major obstacle for drug design is the limited knowl- vided by the structure of the complex between β2 adrenergic re- edge of conformational changes upon agonist binding, the details ceptor and GαsSβ1γ2 (16). This structure reveals—as many previous of interaction with the different G proteins, and the transmission studies had suggested—that the α-subunit is the main interaction to movements within the G protein. Although a variety of differ- partner of the GPCR. Nevertheless, how the GPCR discrim- ent GPCR/G protein complex structures would be needed, the tran- inates between the different α-subunits and how the βγ-dimer sient nature of this complex and the intrinsic instability against influences this interaction has not been definitively answered dissociation make this endeavor very challenging. We have pre- yet. To this end, additional structures of GPCR/G-protein com- viously evolved GPCR mutants that display higher stability and plexes are needed that could shed more light on these questions.
    [Show full text]
  • G Protein Mutations in Endocrine Diseases
    European Journal of Endocrinology (2001) 145 543±559 ISSN 0804-4643 INVITED REVIEW G protein mutations in endocrine diseases Andrea Lania, Giovanna Mantovani and Anna Spada Institute of Endocrine Sciences, Ospedale Maggiore IRCCS, University of Milan, Via F. Sforza 35, 20122 Milano, Italy (Correspondence should be addressed to A Spada, Istituto di Scienze Endocrine, Pad. Granelli, Ospedale Maggiore IRCCS, Via Francesco Sforza 35, 20122 Milano, Italy; Email: [email protected]) Abstract This review summarizes the pathogenetic role of naturally occurring mutations of G protein genes in endocrine diseases. Although in vitro mutagenesis and transfection assays indicate that several G proteins have mitogenic potential, to date only two G proteins have been identi®ed which harbor naturally occurring mutations, Gsa, the activator of adenylyl cyclase and Gi2a, which is involved in several functions, including adenylyl cyclase inhibition and ion channel modulation. The gene encoding Gsa (GNAS1) may be altered by loss or gain of function mutations. Indeed, heterozygous inactivating germ line mutations in this gene cause pseudohypoparathyroidism type Ia, in which physical features of Albright hereditary osteodystrophy (AHO) are associated with resistance to several hormones, i.e. PTH, TSH and gonadotropins, that activate Gs-coupled receptors or pseudopseudohypoparathyroidism in which AHO is the only clinical manifestation. Evidence suggests that the variable and tissue-speci®c hormone resistance observed in PHP Ia may result from tissue- speci®c imprinting of the GNAS1 gene, although the Gsa knockout model only in part reproduces the human AHO phenotype. Activating somatic Gsa mutations leading to cell proliferation have been identi®ed in endocrine tumors constituted by cells in which cAMP is a mitogenic signal, i.e.
    [Show full text]
  • Gi/O Protein-Dependent and -Independent Actions of Pertussis Toxin (PTX)
    Toxins 2011, 3, 884-899; doi:10.3390/toxins3070884 OPEN ACCESS toxins ISSN 2072-6651 www.mdpi.com/journal/toxins Article Gi/o Protein-Dependent and -Independent Actions of Pertussis Toxin (PTX) Supachoke Mangmool 1 and Hitoshi Kurose 2,* 1 Department of Pharmacology, Faculty of Pharmacy, Mahidol University, 447 Sri-Ayudhaya, Rajathevi, Bangkok 10400, Thailand; E-Mail: [email protected] 2 Department of Pharmacology and Toxicology, Graduate School of Pharmaceutical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan * Author to whom correspondence should be addressed; E-Mail: [email protected]; Tel.: +81-92-642-6884; Fax: +81-92-642-6884. Received: 13 April 2011; in revised form: 14 June 2011 / Accepted: 16 June 2011 / Published: 15 July 2011 Abstract: Pertussis toxin (PTX) is a typical A-B toxin. The A-protomer (S1 subunit) exhibits ADP-ribosyltransferase activity. The B-oligomer consists of four subunits (S2 to S5) and binds extracellular molecules that allow the toxin to enter the cells. The A-protomer ADP-ribosylates the α subunits of heterotrimeric Gi/o proteins, resulting in the receptors being uncoupled from the Gi/o proteins. The B-oligomer binds proteins expressed on the cell surface, such as Toll-like receptor 4, and activates an intracellular signal transduction cascade. Thus, PTX modifies cellular responses by at least two different signaling pathways; ADP-ribosylation of the Gαi/o proteins by the A-protomer (Gi/o protein-dependent action) and the interaction of the B-oligomer with cell
    [Show full text]